Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
34.80
+1.16 (3.45%)
At close: Mar 6, 2026

SHA:688253 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
422.03621.39478.02446.62326.91
Revenue Growth (YoY)
-32.08%29.99%7.03%36.62%-68.48%
Cost of Revenue
-127.53140.51173.9477.24
Gross Profit
422.03493.86337.51272.67249.67
Selling, General & Admin
-149.6299.1190.8483.96
Research & Development
-97.1753.1172.1831.11
Other Operating Expenses
261.513.011.448.892.87
Operating Expenses
261.51253.83158.57178.08117.58
Operating Income
160.53240.03178.9494.59132.09
Interest Expense
--0.11-0.2-0.41-0.13
Interest & Investment Income
-30.7424.5712.113.59
Currency Exchange Gain (Loss)
-1.140.5742.65-9.76
Other Non Operating Income (Expenses)
0.1-3.920.34-0.6-0.11
EBT Excluding Unusual Items
160.62267.87204.22148.35125.68
Gain (Loss) on Sale of Investments
-7.469.152.230.89
Gain (Loss) on Sale of Assets
--0.1-0.010.01-
Asset Writedown
---19.54--0
Other Unusual Items
-1.294.5413.9211.24
Pretax Income
160.62276.53198.36164.51137.81
Income Tax Expense
14.5829.6724.4113.8217.65
Earnings From Continuing Operations
146.04246.86173.95150.68120.16
Minority Interest in Earnings
----0.09
Net Income
146.04246.86173.95150.68120.25
Net Income to Common
146.04246.86173.95150.68120.25
Net Income Growth
-40.84%41.92%15.44%25.31%-78.96%
Shares Outstanding (Basic)
136136136122102
Shares Outstanding (Diluted)
136136136122102
Shares Change (YoY)
0.08%0.36%11.83%19.24%2.90%
EPS (Basic)
1.071.811.281.241.18
EPS (Diluted)
1.071.811.281.241.18
EPS Growth
-40.88%41.41%3.23%5.08%-79.55%
Free Cash Flow
-269.31242.8968.7142.52
Free Cash Flow Per Share
-1.981.790.560.42
Dividend Per Share
-0.5600.4000.166-
Dividend Growth
-40.00%140.96%--
Gross Margin
100.00%79.48%70.60%61.05%76.37%
Operating Margin
38.04%38.63%37.43%21.18%40.41%
Profit Margin
34.61%39.73%36.39%33.74%36.79%
Free Cash Flow Margin
-43.34%50.81%15.38%13.01%
EBITDA
179.22258.72200.92111.08145.29
EBITDA Margin
42.47%41.64%42.03%24.87%44.45%
D&A For EBITDA
18.718.721.9816.4913.21
EBIT
160.53240.03178.9494.59132.09
EBIT Margin
38.04%38.63%37.43%21.18%40.41%
Effective Tax Rate
9.08%10.73%12.31%8.40%12.80%
Revenue as Reported
-621.39478.02446.62326.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.